文献速递脊柱关节炎

老年中轴型脊柱关节炎合并癌症患者的生存结局

Survival Outcomes in Older Adults With Axial Spondyloarthritis and Concomitant Cancer.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2026-10-05

基于Medicare与SEER链接数据的 population-based 研究,纳入≥66岁合并乳腺癌、前列腺癌、肺癌或结直肠癌的中轴型脊柱关节炎(axSpA)患者及匹配对照,比较5年总生存(OS)与癌症特异性生存(CSS)。结果显示乳腺癌、前列腺癌、肺癌患者合并axSpA与对照的OS和CSS无显著差异;结直肠癌合并axSpA者OS和CSS反而更高。

要点

  • 老年axSpA合并乳腺癌、前列腺癌或肺癌者,5年OS和CSS与无axSpA对照无显著差异。
  • 老年axSpA合并结直肠癌者,5年OS(aHR 0.78)和CSS(aHR 0.76)优于对照。
  • 研究采用Medicare与SEER链接数据,按癌症类型、年龄、性别、分期和诊断年份匹配对照。

核心结论

  • 老年axSpA合并乳腺癌、前列腺癌或肺癌患者与无axSpA对照的OS和CSS相似。
  • 老年axSpA合并结直肠癌患者与对照相比,OS和CSS更高。

研究设计与样本

  • 基于Medicare索赔数据链接SEER数据的population-based研究,纳入2006年1月至2019年12月诊断的≥66岁原位、局部、区域或远处乳腺癌、前列腺癌、肺癌或结直肠癌患者。
  • axSpA患者按癌症类型、癌症诊断年龄、性别、分期和癌症诊断年份与2至5名无axSpA对照匹配。
  • 共纳入6,095例axSpA患者(乳腺癌2,061例、前列腺癌1,988例、肺癌1,229例、结直肠癌817例)和30,386名对照。
  • 采用Kaplan-Meier分析和log-rank检验估计5年OS和CSS,并按癌症类型分层行Cox比例风险回归,CSS在竞争风险框架下分析。

主要发现

  • axSpA患者平均年龄范围为74岁(乳腺癌、前列腺癌、肺癌)至77岁(结直肠癌)。
  • 乳腺癌、前列腺癌或肺癌合并axSpA患者与对照相比,OS或CSS率无统计学显著差异。
  • 结直肠癌合并axSpA患者5年OS的aHR为0.78(95%CI 0.67-0.91,P=0.002),高于对照。
  • 结直肠癌合并axSpA患者5年CSS的aHR为0.76(95%CI 0.59-0.99,P=0.04),高于对照。

临床怎么用

  • 对老年axSpA合并乳腺癌、前列腺癌或肺癌患者,癌症生存预期可与无axSpA者同等对待。
  • 对老年axSpA合并结直肠癌患者,观察到的OS和CSS更高,临床决策时可参考该预后信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of this study was to determine survival outcomes in older adults with axial spondyloarthritis (axSpA) and concomitant cancer. METHODS: We conducted a population-based study using Medicare claims data linked to Surveillance, Epidemiology, and End Results data to determine overall survival (OS) and cancer-specific survival (CSS) in patients aged ≥66 years with in situ, localized, regional, or distant breast cancer (BC), prostate cancer (PCa), lung cancer (LC), or colorectal cancer (CRC), with and without axSpA, diagnosed January 2006 to December 2019, using International Classification of Diseases for Oncology, 3rd Edition (ICD-O-3) site and histology codes. Patients with axSpA were matched to two to five controls without axSpA using cancer type, age at cancer diagnosis, sex, stage, and year of cancer diagnosis. We censored OS and CSS at five years and estimated rates using Kaplan-Meier analyses with log-rank tests. Stratified Cox proportional hazard regression models were performed for each cancer type, with CSS analyzed under the competing risks framework. RESULTS: We included 6,095 patients (2,061 BC, 1,988 PCa, 1,229 LC, 817 CRC) with axSpA and 30,386 controls. Mean ages ranged from 74 (BC, PCa, LC) to 77 (CRC) years. No statistically significant differences in OS or CSS rates were observed between patients with BC, PCa, or LC and axSpA compared to controls. Patients with CRC and axSpA had higher five-year OS (adjusted hazard ratio [aHR] 0.78, 95% confidence interval [CI] 0.67-0.91, P = 0.002) and CSS (aHR 0.76, 95% CI 0.59-0.99, P = 0.04) compared to controls. CONCLUSION: Older patients with axSpA and BC, PCa, or LC had similar OS and CSS compared to controls. Among patients with CRC, axSpA was associated with higher OS and CSS.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Bowman S, Li M, Lei X, et al. Survival Outcomes in Older Adults With Axial Spondyloarthritis and Concomitant Cancer. Arthritis Care Res (Hoboken). 2026. PMID: 42834520. doi:10.1002/acr.80178

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。